OBJECTIVE: The literature has shown that cognitive and emotional changes may occur after chronic treatment with glucocorticoids. This might be caused by the suppressive effect of glucocorticoids on hippocampal neurogenesis and cell proliferation. Paroxetine, a selective serotonin reuptake transporter, is a commonly used antidepressant for alleviation of signs and symptoms of clinical depression. It was discovered to promote hippocampal neurogenesis in the past few years and we wanted to investigate its interaction with glucocorticoid in this study. METHODS: Adult rats were given vehicle, corticosterone, paroxetine, or both corticosterone and paroxetine for 14 d. Cell proliferation in the dentate gyrus was quantified using 5-bromo-2-deoxyuridine (BrdU) immunohistochemistry. RESULTS: The corticosterone treatment suppressed while paroxetine treatment increased hippocampal cell proliferation. More importantly, paroxetine treatment could reverse the suppressive effect of corticosterone on hippocampal cell proliferation. CONCLUSION: This may have clinic application in preventing hippocampal damage after glucocorticoid treatment.
OBJECTIVE: The literature has shown that cognitive and emotional changes may occur after chronic treatment with glucocorticoids. This might be caused by the suppressive effect of glucocorticoids on hippocampal neurogenesis and cell proliferation. Paroxetine, a selective serotonin reuptake transporter, is a commonly used antidepressant for alleviation of signs and symptoms of clinical depression. It was discovered to promote hippocampal neurogenesis in the past few years and we wanted to investigate its interaction with glucocorticoid in this study. METHODS: Adult rats were given vehicle, corticosterone, paroxetine, or both corticosterone and paroxetine for 14 d. Cell proliferation in the dentate gyrus was quantified using 5-bromo-2-deoxyuridine (BrdU) immunohistochemistry. RESULTS: The corticosterone treatment suppressed while paroxetine treatment increased hippocampal cell proliferation. More importantly, paroxetine treatment could reverse the suppressive effect of corticosterone on hippocampal cell proliferation. CONCLUSION: This may have clinic application in preventing hippocampal damage after glucocorticoid treatment.
Authors: A K Walker; P D Rivera; Q Wang; J-C Chuang; S Tran; S Osborne-Lawrence; S J Estill; R Starwalt; P Huntington; L Morlock; J Naidoo; N S Williams; J M Ready; A J Eisch; A A Pieper; J M Zigman Journal: Mol Psychiatry Date: 2014-04-22 Impact factor: 15.992
Authors: Natalia Elizalde; Alvaro L García-García; Susan Totterdell; Nerea Gendive; Elisabet Venzala; Maria J Ramirez; Joaquin Del Rio; Rosa M Tordera Journal: Psychopharmacology (Berl) Date: 2010-04-20 Impact factor: 4.530
Authors: Denis J David; Benjamin Adam Samuels; Quentin Rainer; Jing-Wen Wang; Douglas Marsteller; Indira Mendez; Michael Drew; Douglas A Craig; Bruno P Guiard; Jean-Philippe Guilloux; Roman P Artymyshyn; Alain M Gardier; Christophe Gerald; Irina A Antonijevic; E David Leonardo; René Hen Journal: Neuron Date: 2009-05-28 Impact factor: 17.173
Authors: Benjamin H Singer; Emily M Jutkiewicz; Cynthia L Fuller; Robin J Lichtenwalner; Helen Zhang; Alan J Velander; Xiangquan Li; Margaret E Gnegy; Charles F Burant; Jack M Parent Journal: J Comp Neurol Date: 2009-06-20 Impact factor: 3.215
Authors: Francis L Pazini; Mauricio P Cunha; Julia M Rosa; André R S Colla; Vicente Lieberknecht; Ágatha Oliveira; Ana Lúcia S Rodrigues Journal: Mol Neurobiol Date: 2015-12-11 Impact factor: 5.590